---
layout: minimal-medicine
title: Pancuronium
---

# Pancuronium
### Generic Name
Pancuronium

### Usage

Pancuronium is a neuromuscular-blocking agent primarily used as an adjunct to general anesthesia.  Its main purpose is to cause temporary paralysis of skeletal muscles, facilitating procedures such as tracheal intubation (insertion of a breathing tube) and providing muscle relaxation during surgery or mechanical ventilation.  While not its primary indication, it may also be used in intensive care units (off-label) to aid in mechanical ventilation for specific conditions like acute respiratory distress syndrome (ARDS) or to manage shivering during therapeutic hypothermia.  However, this off-label use requires careful monitoring and is usually limited to short-term applications.


### Dosage

Dosage varies significantly depending on the patient's age, weight, the specific procedure, and the desired level of paralysis.  Always follow the prescribing physician's instructions meticulously.

**Adults:**

* **Intubation, Surgery, Mechanical Ventilation:** The initial intravenous (IV) dose typically ranges from 0.04 to 0.1 mg/kg.  A lower dose (0.05 mg/kg) might follow an initial dose of succinylcholine for intubation. Maintenance doses of 0.01 mg/kg are administered every 25 to 60 minutes, depending on the duration of the procedure and the patient's response.  A "priming" dose of 10% of the intubation dose, given 3-5 minutes beforehand, may be used.
* **Intensive Care Unit (Off-label):**  The dosage in this setting is much more individualized and often involves continuous infusion.  A bolus dose of 0.06-0.1 mg/kg may be followed by an infusion of 1-2 mcg/kg/min (or 0.8-1.7 mcg/kg/min, depending on individual response).

**Children:**

Dosage for children is considerably lower and is determined by weight and the specific clinical circumstances.  It is often administered as intermittent IV boluses (0.05-0.15 mg/kg every 4-6 hours) or as a continuous IV infusion (0.4-1 mcg/kg/min).  Precise dosage and method must be determined by a pediatric anesthesiologist or intensivist.

**Dosage Adjustments:**  Renal and hepatic impairment significantly impact pancuronium elimination. Reduced doses are needed in patients with renal or liver disease.  In severe cases, the use of pancuronium may be contraindicated.


### Side Effects

**Common:** While generally well-tolerated when used appropriately, side effects can occur.  These include:


* Flushing
* Increased blood pressure
* Increased heart rate
* Increased cardiac workload
* Transient skin rash
* Excessive salivation (sialorrhea)


**Serious (less common):** In rare instances, serious side effects can manifest.  These include:

* Anaphylactic or anaphylactoid reactions (severe allergic responses)
* Bronchospasm
* Hypotension (low blood pressure)
* Tachycardia (rapid heart rate)
* Prolonged paralysis (if not properly managed)

**Important Note:**  If any side effects, whether common or serious, occur, immediately contact your doctor or healthcare provider.


### How it Works

Pancuronium works by competitively blocking the action of acetylcholine at the neuromuscular junction.  Acetylcholine is a neurotransmitter crucial for muscle contraction. By blocking acetylcholine's binding to its receptors, pancuronium prevents muscle fibers from receiving the signal to contract, resulting in temporary paralysis.


### Precautions

* **Hypersensitivity:** Pancuronium is contraindicated in individuals with known hypersensitivity to pancuronium, bromides, or any component of the formulation. A history of allergic reactions to other neuromuscular blockers increases the risk of a reaction.
* **Renal and Hepatic Impairment:**  Patients with kidney or liver problems require dose adjustments due to impaired drug elimination.
* **Pregnancy and Lactation:** Pancuronium should only be used during pregnancy if the potential benefits clearly outweigh the risks to the fetus.  The drug's excretion in breast milk is unknown, necessitating caution during breastfeeding.
* **Neonates and Infants:** Pancuronium formulations containing benzyl alcohol are contraindicated in neonates.  Use in infants requires careful monitoring and dose adjustment.
* **Drug Interactions:**  Pancuronium's effects can be altered by various drugs, including aminoglycosides, inhalational anesthetics, calcium channel blockers, and magnesium salts. Consult your doctor about potential interactions with other medications.
* **Obese and Elderly Patients:** These populations may experience prolonged effects due to altered drug distribution and metabolism. Careful monitoring is essential.

### FAQs

* **Q: How long does the effect of pancuronium last?** A: The duration varies depending on the dose, individual patient factors, and the presence of other medications.  It generally lasts for 30-60 minutes, but it can be significantly longer.
* **Q: How is the effect of pancuronium reversed?** A:  Specific reversal agents (like neostigmine) are used to counteract the effects of pancuronium. This is crucial for restoring muscle function after surgery or procedures.
* **Q:  Can I take pancuronium at home?** A: No, pancuronium is administered exclusively in a hospital or clinic setting by qualified medical personnel. It requires careful monitoring and respiratory support.
* **Q:  How should I store pancuronium?** A: Follow the storage instructions provided on the packaging.  Generally, it should be kept at room temperature, protected from light and moisture.


**Disclaimer:** This information is intended for general knowledge and should not be considered medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The information provided here is based on currently available data, but drug information is constantly evolving.  Always refer to the most up-to-date prescribing information for the most accurate and current details.
